SCHEMBL19928396

SCHEMBL19928396

CC(C)Nc1nc(-c2ccc(C(=O)O)cc2)ccc1C(=O)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.46
LDHB P07195 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.40
HCAR3 P49019 1/20 0.40
PIM3 Q86V86 5/20 0.40
PIM1 P11309 2/20 0.40
CSNK2A1 P68400 2/20 0.40
PIM2 Q9P1W9 2/20 0.40
PIK3CD O00329 1/20 0.40
DYRK3 O43781 1/20 0.40
CDK2 P24941 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
GSK3B P49841 1/20 0.40
RAB9A P51151 4/20 0.39
KDM4E B2RXH2 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20256989 0.88 LDHA (0.46) LDHALDHBSMN1; SMN2HCAR3PIM3
SCHEMBL19928398 0.86 LDHA (0.49) LDHALDHBPIM1CSNK2A1GAA
SCHEMBL19928403 0.85 SMN1; SMN2 (0.43) LDHALDHBSMN1; SMN2HCAR3PIM3
SCHEMBL15131330 0.85 LDHA (0.44) LDHALDHBSMN1; SMN2HCAR3PIM3
SCHEMBL18019282 0.72 SMN1; SMN2 (0.44) LDHALDHBSMN1; SMN2CSNK2A1PIK3CG
SCHEMBL15131447 0.72 LDHA (0.47) LDHALDHBPIM1CSNK2A1ALDH1A1
SCHEMBL19928394 0.72 LDHA (0.46) LDHALDHBPIK3CACAMK2D
SCHEMBL20256988 0.69 SMN1; SMN2 (0.46) LDHALDHBSMN1; SMN2HCAR3PIM3
SCHEMBL15131382 0.69 SMN1; SMN2 (0.41) LDHALDHBSMN1; SMN2RAB9AKDM4E
SCHEMBL20256902 0.69 SMN1; SMN2 (0.45) LDHALDHBSMN1; SMN2RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673890-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2023-06-13 US disclosed
US-20210047325-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2021-02-18 US disclosed
US-10822335-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2020-11-03 US disclosed
US-20190218218-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2019-07-18 US disclosed
US-9908883-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2018-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11673890-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC LDHA 499/4885LDHB 976/4885SMN1; SMN2 2884/4885
US-20190218218-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC LDHA 488/4885LDHB 950/4885SMN1; SMN2 3027/4885
US-20210047325-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC LDHA 499/4885LDHB 976/4885SMN1; SMN2 2884/4885
US-10822335-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC LDHA 478/4885LDHB 951/4885SMN1; SMN2 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.